Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?

Abstract

Gangil J, Thunga G, Nagaich R

Today many countries either fail to provide protection or the protection that they provide falls below the levels required by Trade Related Aspects of Intellectual Property Rights (TRIPS). Data exclusivity is one of the most interesting issues in the current discussion on pharmaceutical intellectual property policy making on the global pitch. Data exclusivity, also known as marketing exclusivity, refers to a practice whereby, for a fixed period of time, drug regulatory authorities do not allow the registration files of a pioneer company to be used to register a therapeutically equivalent generic version of that medicine. Only with a clear understanding of the data exclusivity issue and a concerted effort by governments and industries, such as the pharmaceutical industry, that are required to provide registration data to governments have the assurances that their extensive efforts to research, develop, and bring new, innovative products to market will not be subject to unfair business use. Data exclusivity also plays a key role in the development and marketing of new biologics.

How to Cite this Article
Pubmed Style

Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. 2010; 1(2): 190-193.
doi:10.4103/0975-8453.75088

Web Style

Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. http://www.sysrevpharm.org/?mno=302644624 [Access: March 28, 2021]. doi:10.4103/0975-8453.75088

AMA (American Medical Association) Style

Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. 2010; 1(2): 190-193. doi:10.4103/0975-8453.75088



Vancouver/ICMJE Style

Gangil J, Thunga G, Nagaich R. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP. (2010), [cited March 28, 2021]; 1(2): 190-193. doi:10.4103/0975-8453.75088



Harvard Style

Gangil J, Thunga G, Nagaich R (2010) Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. SRP, 1 (2), 190-193. doi:10.4103/0975-8453.75088



Turabian Style

Gangil J, Thunga G, Nagaich R. 2010. Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. Systematic Reviews in Pharmacy, 1 (2), 190-193. doi:10.4103/0975-8453.75088



Chicago Style

Gangil J, Thunga G, Nagaich R. "Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?." Systematic Reviews in Pharmacy 1 (2010), 190-193. doi:10.4103/0975-8453.75088



MLA (The Modern Language Association) Style

Gangil J, Thunga G, Nagaich R. "Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?." Systematic Reviews in Pharmacy 1.2 (2010), 190-193. Print. doi:10.4103/0975-8453.75088



APA (American Psychological Association) Style

Gangil J, Thunga G, Nagaich R (2010) Do Intellectual Property Rights and Data Exclusivity Encourage Innovation in the Pharmaceutical World?. Systematic Reviews in Pharmacy, 1 (2), 190-193. doi:10.4103/0975-8453.75088

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3